Repurposing CRISPR/Cas to Discover SARS‐CoV‐2 Detecting and Neutralizing Aptamers
Ju Zhang,Airu Zhu,Miao Mei,Jing Qu,Yalan Huang,Yongshi Shi,Meiying Xue,Jingfang Zhang,Renli Zhang,Bing Zhou,Xu Tan,Jincun Zhao,Yu Wang
DOI: https://doi.org/10.1002/advs.202300656
IF: 15.1
2023-05-21
Advanced Science
Abstract:CRISmers, a novel system for screening RNA aptamers, provides an endogenous biological context for the folding of aptamersand proteins, and their interaction. Performance of CRISmers is showcased by identification of a potent neutralizing aptamer against the live severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron variant in vivo. Further, CRISmers is compatible with varying systems, host species, and cellular enrichment methods. RNA aptamers provide useful biological probes and therapeutic agents. New methodologies to screen RNA aptamers will be valuable by complementing the traditional Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Meanwhile, repurposing clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated systems (Cas) has expanded their utility far beyond their native nuclease function. Here, CRISmers, a CRISPR/Cas‐based novel screening system for RNA aptamers based on binding to a chosen protein of interest in a cellular context, is presented. Using CRISmers, aptamers are identified specifically targeting the receptor binding domain (RBD) of the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Two aptamer leads enable sensitive detection and potent neutralization of SARS‐CoV‐2 Delta and Omicron variants in vitro. Intranasal administration of one aptamer, further modified with 2'‐fluoro pyrimidines (2'‐F), 2'‐O‐methyl purines (2'‐O), and conjugation with both cholesterol and polyethylene glycol of 40 kDa (PEG40K), achieves effective prophylactic and therapeutic antiviral activity against live Omicron BA.2 variants in vivo. The study concludes by demonstrating the robustness, consistency, and potential broad utility of CRISmers using two newly identified aptamers but switching CRISPR, selection marker, and host species.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry